More MS news articles for Nov 2001

NIH Posts Stem-Cell Registry

WASHINGTON (Reuters Health) Nov 08 - The National Institutes of Health (NIH) has posted a long-awaited registry of embryonic stem-cell lines that can be used in federally funded research.

At present, the registry lists 11 institutions and companies that between them have 72 permissible stem-cell lines at various stages of development.

According to the NIH, each of these lines has been shown to meet President Bush's criteria announced in August. At the time, the president said he would permit the use of federal funds for research on stem-cell lines derived before August 9 with the consent of the embryo's donors. The lines also are required to be derived from an excess embryo created for reproductive purposes and donated without financial incentive.

According to the registry, Athens, Georgia-based BresaGen has four acceptable lines, Menlo Park, California-based Geron has seven and San Diego, California-based CyThera has nine. Australia's ES Cell International has six.

Among academic institutions, Sweden's Goteborg University has the largest number of acceptable lines, totalling 19.

"If investigators or institutions have additional human embryonic stem cell lines that they believe are eligible for listing on the registry, please contact NIH at," the federal research institution added in an appeal for additional resources.

Scientists familiar with the cell lines have confirmed that some are well-established and ready for studies. However, some questions remain about the degree to which academics will be able to gain access to privately-owned lines and how well the lines will stand up to research.

The stem-cell registry can be accessed on the NIH Web site at Investigators wishing to apply for federal funds can find instructions at

Copyright © 2001 Reuters Ltd